Godsey & Gibb Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.1K | Hold |
455
| – | – | ﹤0.01% | 213 |
|
|
2025
Q1 | $27.8K | Hold |
455
| – | – | ﹤0.01% | 205 |
|
|
2024
Q4 | $25.7K | Hold |
455
| – | – | ﹤0.01% | 208 |
|
|
2024
Q3 | $23.5K | Sell |
455
-1,179
| -72% | -$61K | ﹤0.01% | 243 |
|
|
2024
Q2 | $67.8K | Buy |
1,634
+1,509
| +1,207% | +$62.7K | 0.01% | 168 |
|
|
2024
Q1 | $6.78K | Sell |
125
-300
| -71% | -$16.3K | ﹤0.01% | 301 |
|
|
2023
Q4 | $21.8K | Sell |
425
-300
| -41% | -$15.4K | ﹤0.01% | 215 |
|
|
2023
Q3 | $42.1K | Hold |
725
| – | – | 0.01% | 170 |
|
|
2023
Q2 | $46.4K | Hold |
725
| – | – | 0.01% | 173 |
|
|
2023
Q1 | $50.3K | Hold |
725
| – | – | 0.01% | 164 |
|
|
2022
Q4 | $52.2K | Buy |
+725
| New | +$52.2K | 0.01% | 117 |
|
|
2021
Q1 | – | Sell |
-3,592
| Closed | -$223K | – | 104 |
|
|
2020
Q4 | $223K | Buy |
+3,592
| New | +$223K | 0.03% | 93 |
|
|
2020
Q3 | – | Sell |
-5,550
| Closed | -$326K | – | 82 |
|
|
2020
Q2 | $326K | Buy |
5,550
+1,350
| +32% | +$79.3K | 0.05% | 69 |
|
|
2020
Q1 | $234K | Buy |
4,200
+300
| +8% | +$16.7K | 0.04% | 75 |
|
|
2019
Q4 | $250K | Sell |
3,900
-150
| -4% | -$9.62K | 0.04% | 84 |
|
|
2019
Q3 | $205K | Sell |
4,050
-712
| -15% | -$36K | 0.03% | 87 |
|
|
2019
Q2 | $216K | Buy |
+4,762
| New | +$216K | 0.03% | 84 |
|